We provide you with 20 years of free, institutional-grade data for ABCM stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ABCM. Explore the full financial landscape of ABCM stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about ABCM stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Abcam plc(NASDAQ:ABCM) 
Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including...
Website: http://abcam.com
Founded: 1998
Full Time Employees: 1,492
CEO: Alan Thomas Hirzel
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends